LongevityLeak

Polyphenol signaling

Resveratrol

Resveratrol may improve glucose and inflammation markers, but effects are usually modest and depend on dose and formulation quality.

Evidence Level B

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Small-to-modest cardiometabolic biomarker improvements
Safety
Low Risk

Bioavailability is a major limiter.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
150-500 mg (trans-resveratrol equivalent)
Timing
With meals, frequently alongside fats
Protocol Duration in Studies
8-24 weeks across cardiometabolic studies

Formulation and absorption enhancers can materially change effective exposure.

Best Fit Profiles

  • polyphenol longevity stacks

Source Links